ClinicalTrials.Veeva

Menu

The Effects of Serratus Anterior Plane Block on Postoperative Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Postoperative Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery

Treatments

Drug: Normal Saline
Drug: Ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02311517
4-2014-0853

Details and patient eligibility

About

Postoperative pain still remains a challenging problem in patients undergoing video-assisted thoracoscopic surgery (VATS). However, there is no gold standard for regional analgesia for VATS. Serratus anterior plane block (SPB) under ultrasound guidance has been described recently to achieve complete paresthesia of the hemithorax. Therefore, SPB has the possibility to provide analgesia following thoracic surgery. Pain following surgery is a critical side effect of surgery, which increases the risk of complications and delays a recovery. Therefore, SPB may help not only reduce pain following VATS, but also increase the quality of recovery. This study aims to investigate the effectiveness of ultrasound-guided SPB on the quality of recovery and pain in patients undergoing VATS.

Enrollment

90 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult patients (20-65 years of age) scheduled for elective video-assisted thoracoscopic surgery
  2. ASA class I and II

Exclusion criteria

  1. Allergy to local anesthetics or contraindication to use of ropivacaine
  2. Pregnancy
  3. Neurologic and psychologic disease
  4. Severe cardiovascular disease
  5. Liver failure
  6. Renal failure
  7. Chronic treatment with analgesics

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups, including a placebo group

ropivacaine group
Experimental group
Description:
45 patients will be randomly allocated into ropivacaine group with 0.4 ml/kg of 0.375% ropivacaine after induction of anesthesia.
Treatment:
Drug: Ropivacaine
saline group
Placebo Comparator group
Description:
40 patients are randomly allocated into saline group with 0.4 ml/kg saline after induction of anesthesia.
Treatment:
Drug: Normal Saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems